Global Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, Irreversible Electroporation, Other Technologies), Treatment, Application, End User, Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2018 to 2025

  • Publish Date: Mar, 2019
  • Report ID: 375995
  • Category: Medical Devices
  • Pages: 0
$4,700

Global tumor ablation market is expected to reach from USD 964.08 Million in 2017 to USD 2,474.31 Million by 2025 at a CAGR of 12.40% from 2018 to 2025. Increasing awareness about ablation procedure over other surgical procedures and high demand for minimally invasive cancer treatment procedure are contributing to the growth of the market.

Market Overview:

Image-guided techniques like tumor ablation have become a powerful tool for the treatment of certain benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues and pain palliation. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver and other areas of patients’ body. The change in lifestyle and unhealthy eating habits, including increasing consumption of tobacco and alcohol, is the leading cause of the rise in some cancer cases. According to the National Cancer Institute (NCI), in 2016 around 1,685,210 new cases of cancer were diagnosed in the U.S. Increasing prevalence of cancer cases worldwide is driving the growth of the market. As per the statistics by the World Health Organization (WHO), about 13.0% of the population suffers from cancer every year. These tools offer various benefits such as less trauma and speedy recovery.

Report Description:

  • The base year for the study has been considered 2017, the historic year 2015 and 2016 and, the forecast period considered is from 2018 to 2025. The global tumor ablation market is analyzed by value (USD Million).
  • The study delivers a comprehensive analysis of the global tumor ablation market by technology, treatment, application, end user and regions.
  • The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2018 to 2025.
  • Porter’s Five Forces model is used to recognize the competitive scenario in the global tumor ablation market. This report incorporates the industry analysis which is focused on providing an extensive view of the global tumor ablation market.
  • The study also includes attractiveness analysis technology, treatment, application, end user and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
  • The report provides company profile of the key players operating in the global tumor ablation market and a comparative analysis based on their business overviews, product offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
  • The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.

Market Dynamics: 

Drivers:

  • Increasing cases of cancer worldwide
  • Growing demand for minimally invasive procedures
  • Technological advancements in the field of thermal ablation
  • Rise in awareness about various cancer types and increasing R&D activities

Restraints:

  • The high cost of ablation techniques
  • Limited reimbursement policy

Opportunities:

  • Innovation in the technology required in the tumor ablation

Challenges:

  • Usage only in minor surgeries

Global Tumor Ablation Market Key Findings:

All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment.

Segmentation Analysis:

The global tumor ablation market is segmented by technology, treatment, application, and end user.

  • The technology segment is classified into the microwave, radiofrequency, cryoablation, and other technologies. The radiofrequency technology segment held the largest market share of 38.17% in 2017. The major application of this technology in solid tumor removal contributed to its growth. In this technology, imaging devices and needle electrode probe pierced through the skin and high-frequency currents pass through the electrode to generate heat to destroy tumor cells.
  • Treatment segment is divided into surgical, laparoscopic, and percutaneous procedures. The surgical segment accounted for the maximum market share and was valued at around USD 414.52 million in 2017. The rising prevalence of liver and breast cancer requiring open surgical procedures has contributed to the growth of the segment.
  • Application segment is bifurcated into liver cancer, breast cancer, lung cancer, prostate cancer, and other types of cancer. Liver cancer segment is expected to register the highest CAGR of 14.68% during the forecast period due to the high prevalence of these cancers.
  • End-user segment is classified into cancer specialty clinics, hospitals, and others. The hospitals held the largest share of around 48.10% in the forecast period. Hospitals segment has recorded the highest growth owing to increasing visitations to hospitals for routine check-ups coupled with the presence of advanced facilities in hospitals.

Regional Segmentation Analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. North America region captured the largest share of the global tumor ablation market and was valued around USD 395.24 Million in 2017 whereas Asia Pacific is expected to witness maximum CAGR in the forecast period.

  • North America region is expected to dominate the market. Major factors contributing to the growth are government support for quality healthcare, high purchasing power, availability of reimbursement, and increasing prevalence of cancers in the region.
  • The Asia Pacific is expected to register the lucrative growth in the forecast period owing to improving healthcare infrastructure in the region. Also, huge population base in the region led to a high demand for affordable treatment options.

Global Tumor Ablation Market Competitive Analysis:

Major players operating in the global tumor ablation market are Galil Medical, Inc., Misonix, Inc., HealthTronics, Angiodynamics, Covidien, Boston Scientific Corporation, Medtronic Plc, SonaCare Medical, EDAP TMS S.A., Neuwave Medical, Inc., Atricure, Inc., Biosense Webster, Inc., Conmed Corporation, Olympus Corporation, Smith & Nephew, St. Jude Medical, Inc. and others. Extensive product portfolio and expansion strategies by major players are contributing for the growth of the sector. For instance, in October 2017, Acutus Medical received approval from US Food and Drug Administration (FDA) for AcQMap. It is high resolution imaging and mapping system. It will enable practitioners to quickly map and re-map changes throughout the ablation procedure.

This study forecasts revenue growth at global, regional, and country levels from 2015 to 2025. Fior Market Research has segmented the global tumor ablation market on the basis of below mentioned segments:

Global Tumor Ablation Market, By Technology:

  • Radiofrequency
  • Microwave
  • Cryoablation
  • Irreversible Electroporation
  • High-Intensity Focused Ultrasound
  • Laser Interstitial Thermal Ablation
  • Other Technologies

Global Tumor Ablation Market, By Treatment:

  • Surgical
  • Laparoscopic
  • Percutaneous

Global Tumor Ablation Market, By Application:

  • Liver Cancer
  • Breast cancer
  • Lung Cancer
  • Prostate Cancer
  • Other Cancer

Global Tumor Ablation Market, By End User:

  • Hospitals
  • Cancer Specialty Clinics
  • Others

Global Tumor Ablation Market, By Regions:

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Sweden
    • Netherlands
    • U.K.
    • Italy
    • Spain
    • Turkey
    • Switzerland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of The Middle East and Africa

*All our reports are customizable as per customer requirements

1. Introduction
   1.1. Objectives of the Study
   1.2. Market Definition
   1.3. Research Scope
   1.4. Currency

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
   4.1. Porter’s Five Forces Analysis
   4.2. Value Chain Analysis
   4.3. Top Investment Pockets
        4.3.1. Market attractiveness analysis by technology
        4.3.2. Market attractiveness analysis by treatment
        4.3.3. Market attractiveness analysis by application
        4.3.4. Market attractiveness analysis by end user
        4.3.5. Market attractiveness analysis by region
   4.4. Industry Trends

5. Market Dynamics
   5.1. Market Evaluation
   5.2. Drivers
        5.2.1. Increasing Cases of Cancer Worldwide
        5.2.2. Growing Demand for Minimally Invasive Procedures
        5.2.3. Technological Advancements in the Field of Thermal Ablation
        5.2.4. Rise in Awareness about Various Cancer Types and Increasing R&D Activities
   5.3. Restraints
        5.3.1. High Cost of Ablation Techniques
        5.3.2. Limited Reimbursement Policy
   5.4. Opportunities
        5.4.1. Innovation in the Technology Required in the Tumor Ablation
   5.5. Challenges
        5.5.1. Usage only in Minor Surgeries

6. Global Tumor Ablation Market Analysis and Forecast, By Technology
   6.1. Segment Overview
   6.2. Radiofrequency
   6.3. Microwave
   6.4. Cryoablation
   6.5. Irreversible Electroporation
   6.6. High-Intensity Focused Ultrasound
   6.7. Laser Interstitial Thermal Ablation
   6.8. Other Technologies

7. Global Tumor Ablation Market Analysis and Forecast, By Treatment
   7.1. Segment Overview
   7.2. Surgical
   7.3. Laparoscopic
   7.4. Percutaneous

8. Global Tumor Ablation Market Analysis and Forecast, By Application
   8.1. Segment Overview
   8.2. Liver Cancer
   8.3. Breast cancer
   8.4. Lung Cancer
   8.5. Prostate Cancer
   8.6. Other Cancer

9. Global Tumor Ablation Market Analysis and Forecast, By End User
   9.1. Segment Overview
   9.2. Hospitals
   9.3. Cancer Specialty Clinics
   9.4. Others

10. Global Tumor Ablation Market Analysis and Forecast, By Regional Analysis
   10.1. Segment Overview
   10.2. North America
        10.2.1. U.S.
        10.2.2. Canada
        10.2.3. Mexico
   10.3. Europe
        10.3.1. Germany
        10.3.2. France
        10.3.3. Sweden
        10.3.4. Netherlands
        10.3.5. U.K.
        10.3.6. Italy
        10.3.7. Spain
        10.3.8. Turkey
        10.3.9. Switzerland
        10.3.10. Belgium
        10.3.11. Rest of Europe
   10.4. Asia-Pacific
        10.4.1. Japan
        10.4.2. China
        10.4.3. India
        10.4.4. South Korea
        10.4.5. Australia
        10.4.6. Singapore
        10.4.7. Malaysia
        10.4.8. Thailand
        10.4.9. Indonesia
        10.4.10. Philippines
        10.4.11. Rest of Asia-Pacific
   10.5. South America
        10.5.1. Brazil
        10.5.2. Argentina
        10.5.3. Colombia
        10.5.4. Rest of South America
   10.6. Middle East and Africa
        10.6.1. Saudi Arabia
        10.6.2. UAE
        10.6.3. Egypt
        10.6.4. Nigeria
        10.6.5. South Africa
        10.6.6. Rest of  Middle East and Africa

11. Global Tumor Ablation Market-Competitive Landscape
   11.1. Overview
   11.2. Market Share of Key Players in the Tumor Ablation Market
        11.2.1. Global Company Market Share
        11.2.2. North America Company Market Share
        11.2.3. Europe Company Market Share
        11.2.4. APAC Company Market Share
   11.3. Competitive Situations and Trends
        11.3.1. Product Launches and Developments
        11.3.2. Partnerships, Collaborations, and Agreements
        11.3.3. Mergers & Acquisitions
        11.3.4. Expansions

12. Company Profiles
   12.1. Galil Medical, Inc.
        12.1.1. Business Overview
        12.1.2. Company Snapshot
        12.1.3. Company Market Share Analysis
        12.1.4. Company Product Portfolio
        12.1.5. Recent Developments
        12.1.6. SWOT Analysis
   12.2. Misonix, Inc.
        12.2.1. Business Overview
        12.2.2. Company Snapshot
        12.2.3. Company Market Share Analysis
        12.2.4. Company Product Portfolio
        12.2.5. Recent Developments
        12.2.6. SWOT Analysis
   12.3. HealthTronics
        12.3.1. Business Overview
        12.3.2. Company Snapshot
        12.3.3. Company Market Share Analysis
        12.3.4. Company Product Portfolio
        12.3.5. Recent Developments
        12.3.6. SWOT Analysis
   12.4. Angiodynamics
        12.4.1. Business Overview
        12.4.2. Company Snapshot
        12.4.3. Company Market Share Analysis
        12.4.4. Company Product Portfolio
        12.4.5. Recent Developments
        12.4.6. SWOT Analysis
   12.5. Covidien
        12.5.1. Business Overview
        12.5.2. Company Snapshot
        12.5.3. Company Market Share Analysis
        12.5.4. Company Product Portfolio
        12.5.5. Recent Developments
        12.5.6. SWOT Analysis
   12.6. Boston Scientific Corporation
        12.6.1. Business Overview
        12.6.2. Company Snapshot
        12.6.3. Company Market Share Analysis
        12.6.4. Company Product Portfolio
        12.6.5. Recent Developments
        12.6.6. SWOT Analysis
   12.7. Medtronic Plc.
        12.7.1. Business Overview
        12.7.2. Company Snapshot
        12.7.3. Company Market Share Analysis
        12.7.4. Company Product Portfolio
        12.7.5. Recent Developments
        12.7.6. SWOT Analysis
   12.8. SonaCare Medical
        12.8.1. Business Overview
        12.8.2. Company Snapshot
        12.8.3. Company Market Share Analysis
        12.8.4. Company Product Portfolio
        12.8.5. Recent Developments
        12.8.6. SWOT Analysis
   12.9. EDAP TMS S.A.
        12.9.1. Business Overview
        12.9.2. Company Snapshot
        12.9.3. Company Market Share Analysis
        12.9.4. Company Product Portfolio
        12.9.5. Recent Developments
        12.9.6. SWOT Analysis
   12.10. Neuwave Medical, Inc.
        12.10.1. Business Overview
        12.10.2. Company Snapshot
        12.10.3. Company Market Share Analysis
        12.10.4. Company Product Portfolio
        12.10.5. Recent Developments
        12.10.6. SWOT Analysis
   12.11. Atricure, Inc.
        12.11.1. Business Overview
        12.11.2. Company Snapshot
        12.11.3. Company Market Share Analysis
        12.11.4. Company Product Portfolio
        12.11.5. Recent Developments
        12.11.6. SWOT Analysis
   12.12. Biosense Webster, Inc.
        12.12.1. Business Overview
        12.12.2. Company Snapshot
        12.12.3. Company Market Share Analysis
        12.12.4. Company Product Portfolio
        12.12.5. Recent Developments
        12.12.6. SWOT Analysis
   12.13. Conmed Corporation l
        12.13.1. Business Overview
        12.13.2. Company Snapshot
        12.13.3. Company Market Share Analysis
        12.13.4. Company Product Portfolio
        12.13.5. Recent Developments
        12.13.6. SWOT Analysis
   12.14. Olympus Corporation
        12.14.1. Business Overview
        12.14.2. Company Snapshot
        12.14.3. Company Market Share Analysis
        12.14.4. Company Product Portfolio
        12.14.5. Recent Developments
        12.14.6. SWOT Analysis
   12.15. Smith & Nephew
        12.15.1. Business Overview
        12.15.2. Company Snapshot
        12.15.3. Company Market Share Analysis
        12.15.4. Company Product Portfolio
        12.15.5. Recent Developments
        12.15.6. SWOT Analysis


List of Table
1. Global Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
2. Global Radiofrequency Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
3. Global Microwave Tumor Ablation Market, By Region, 2015–2025 (USD Million)
4. Global Cryoablation Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
5. Global Irreversible Electroporation Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
6. Global High-Intensity Focused Ultrasound Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
7. Global Laser Interstitial Thermal Ablation Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
8. Global Other Technologies Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
9. Global Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
10. Global Surgical Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
11. Global Laparoscopic Tumor Ablation Market, By Region, 2015–2025 (USD Million)
12. Global Percutaneous Tumor Ablation Market, By Region, 2015–2025 (USD Million)
13. Global Tumor Ablation Market, By Application, 2015–2025 (USD Million)
14. Global Liver Cancer Tumor Ablation Market, By Region, 2015–2025 (USD Million)
15. Global Breast cancer Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
16. Global Lung Cancer Tumor Ablation, By Region, 2015–2025 (USD Million)
17. Global Prostate Cancer Tumor Ablation Market, By Region, 2015–2025 (USD Million)
18. Global Other Cancer Tumor Ablation Market, By Region, 2015–2025 (USD Million)
19. Global Tumor Ablation Market, By End User, 2015–2025 (USD Million)
20. Global Hospitals Tumor Ablation Market, By Region, 2015–2025 (USD Million)
21. Global Cancer Specialty Clinics Tumor Ablation Market, By Region, 2015–2025 (USD Million)
22. Global Others Tumor Ablation Market, By Region, 2015–2025 (USD Million)
23. Global Tumor Ablation Market, By Region, 2015–2025 (USD Million) 
24. North America Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
25. North America Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
26. North America Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
27. North America Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
28. U.S. Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
29. U.S. Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
30. U.S. Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
31. U.S. Tumor Ablation Market, By End User, 2015–2025 (USD Million)
32. Canada Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
33. Canada Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
34. Canada Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
35. Canada Tumor Ablation Market, By End User, 2015–2025 (USD Million)
36. Mexico Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
37. Mexico Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
38. Mexico Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
39. Mexico Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
40. Europe Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
41. Europe Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
42. Europe Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
43. Europe Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
44. Germany Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
45. Germany Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
46. Germany Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
47. Germany Tumor Ablation Market, By End User, 2015–2025 (USD Million)
48. France Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
49. France Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
50. France Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
51. France Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
52. Sweden Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
53. Sweden Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
54. Sweden Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
55. Sweden Tumor Ablation Market, By End User, 2015–2025 (USD Million)
56. Netherlands Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
57. Netherlands Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
58. Netherlands Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
59. Netherlands Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
60. U.K. Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
61. U.K. Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
62. U.K. Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
63. U.K. Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
64. Italy Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
65. Italy Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
66. Italy Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
67. Italy Tumor Ablation Market, By End User, 2015–2025 (USD Million)
68. Spain Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
69. Spain Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
70. Spain Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
71. Spain Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
72. Turkey Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
73. Turkey Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
74. Turkey Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
75. Turkey Tumor Ablation Market, By End User, 2015–2025 (USD Million)
76. Switzerland Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
77. Switzerland Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
78. Switzerland Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
79. Switzerland Tumor Ablation Market, By End User, 2015–2025 (USD Million)
80. Belgium Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
81. Belgium Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
82. Belgium Tumor Ablation Market, By Application, 2015–2025 (USD Million)
83. Belgium Tumor Ablation Market, By End User, 2015–2025 (USD Million)
84. Asia Pacific Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
85. Asia Pacific Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
86. Asia Pacific Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
87. Asia Pacific Tumor Ablation Market, By End User, 2015–2025 (USD Million)
88. Japan Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
89. Japan Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
90. Japan Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
91. Japan Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
92. China Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
93. China Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
94. China Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
95. China Tumor Ablation Market, By End User, 2015–2025 (USD Million)
96. India Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
97. India Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
98. India Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
99. India Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
100. South Korea Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
101. South Korea Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
102. South Korea Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
103. South Korea Tumor Ablation Market, By End User, 2015–2025 (USD Million)
104. Australia Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
105. Australia Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
106. Australia Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
107. Australia Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
108. Singapore Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
109. Singapore Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
110. Singapore Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
111. Singapore Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
112. Malaysia Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
113. Malaysia Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
114. Malaysia Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
115. Malaysia Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
116. Thailand Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
117. Thailand Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
118. Thailand Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
119. Thailand Tumor Ablation Market, By End User, 2015–2025 (USD Million)
120. Indonesia Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
121. Indonesia Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
122. Indonesia Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
123. Indonesia Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
124. Philippines Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
125. Philippines Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
126. Philippines Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
127. Philippines Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
128. South America Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
129. South America Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
130. South America Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
131. South America Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
132. Brazil Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
133. Brazil Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
134. Brazil Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
135. Brazil Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
136. Argentina Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
137. Argentina Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
138. Argentina Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
139. Argentina Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
140. Colombia Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
141. Colombia Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
142. Colombia Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
143. Colombia Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
144. Middle East and Africa Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
145. Middle East and Africa Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
146. Middle East and Africa Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
147. Middle East and Africa Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
148. Saudi Arabia Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
149. Saudi Arabia Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
150. Saudi Arabia Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
151. Saudi Arabia Tumor Ablation Market, By End User, 2015–2025 (USD Million)
152. UAE Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
153. UAE Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
154. UAE Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
155. UAE Tumor Ablation Market, By End User, 2015–2025 (USD Million)
156. Egypt Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
157. Egypt Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
158. Egypt Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
159. Egypt Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
160. Nigeria Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
161. Nigeria Tumor Ablation Market, By Treatment, 2015–2025 (USD Million) 
162. Nigeria Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
163. Nigeria Tumor Ablation Market, By End User, 2015–2025 (USD Million) 
164. South Africa Tumor Ablation Market, By Technology, 2015–2025 (USD Million) 
165. South Africa Tumor Ablation Market, By Treatment, 2015–2025 (USD Million)
166. South Africa Tumor Ablation Market, By Application, 2015–2025 (USD Million) 
167. South Africa Tumor Ablation Market, By End User, 2015–2025 (USD Million)

List of Figures 
1. Global Tumor Ablation Market Segmentation
2. Tumor Ablation Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis 
7. Value Chain Analysis 
8. Global Tumor Ablation Market attractiveness analysis by Technology
9. Global Tumor Ablation Market attractiveness analysis by Treatment
10. Global Tumor Ablation Market attractiveness analysis by Application
11. Global Tumor Ablation Market attractiveness analysis by End User
12. Global Tumor Ablation Market attractiveness analysis by Region
13. Global Tumor Ablation Market: Dynamics
14. Global Tumor Ablation Market Share by Technology (2017 & 2025)
15. Global Tumor Ablation Market Share by Treatment (2017 & 2025)
16. Global Tumor Ablation Market Share by Application (2017 & 2025)
17. Global Tumor Ablation Market Share by End User (2017 & 2025)
18. Global Tumor Ablation Market Share by Regions (2017 & 2025)
19. Global Tumor Ablation Market Share by Company (2018)

Research Methodology

Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.

Market research is valuable because of the following reasons:

  • Market research helps businesses strengthen a company’s position
  • Market research helps in minimizing the investment risks associated with the businesses in any industry vertical
  • Market research helps in identifying the potential threats and opportunities associated with the business industry
  • Market research aids in spotting the emerging trends and facilitates strategic planning in order to stay ahead in the competition

Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.

Our market research process involves with the four specific stages.

  • Data Collection
  • Data Synthesis
  • Market Deduction & Formulation
  • Data Screening & Validation

Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:

  • Primary Research: By conducting primary research, it involves with the two types of data gathering; exploratory and specific. Exploratory data is open-ended and helps us to define a particular problem involving surveys, and pilot study to the specific consumer group, knowing their needs and wants catering to the industry related product/service offering. Explanatory data gathering follows with the bit of unstructured way. Our analyst group leads the study by focusing on the key crowd, in this manner picking up bits of knowledge from them. In light of the points of view of the clients, this data is used to plan advertise techniques. In addition, showcase overviews causes us to comprehend the current scenario of the business. Specific data gathering on the hand, involves with the more structured and formal way. The primary research usually includes in telephonic conversations, E-mail collaborations and up close and personal meetings/interviews with the raw material suppliers, industrial wholesalers, and independent consultants/specialists. The interviews that we conduct offers important information on showcase size and industry development patterns. Our company likewise conducts interviews with the different business specialists so as to increase generally bits of knowledge of the business/showcase.
  • Secondary Research: The secondary research incorporates with the data gathering from the non-profit associations and organizations, for example, World bank, WHO, investor relations and their presentations, statistical databases, yearly(annual reports) reports, national government records, factual databases, websites, articles, white papers, press releases, blogs and others. From the annual report, we deduce an organization's income/revenue generation to comprehend the key product segment related to the market. We examine the organization sites and implement product mapping strategy which is significant for determining the segment revenue. In the product mapping technique, we choose and categorize the products offered by the companies catering to the industry specific market, derive the segment revenue for each of the organizations to get the market estimation. We also gather data & Information based on the supply and demand side of the value chain involved with the domain specific market. The supply side denotes the distributors, wholesalers, suppliers and the demand side denotes the end-consumers/customers of the value chain. The supply side of the market is analyzed by examining the product growth across industry in each of the region followed by its pricing analysis. The demand side is analyzed by the evaluating the penetration level and adoption rates of the product by referring to the historical/past data, examine the present usage and forecasting the future trends. 
  • Purchased Database: Our purchased data provides insights about the key market players/companies along with their financial analysis. Additionally, our data base also includes market related information. 
    • We also have the agreements with various reputed data providers, consultants and third party vendors who provide information which are not limited to:
      • Export & Import Data
      • Business Information related to trade and its statistics
      • Penetration level of a particular product/service based on geography mainly focusing on the unmet prerequisites of the customers.
  • In-house Library: Apart from these third-party sources, we have our in-house library of quantitative and qualitative data & information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, internal audit reports, historic databases, archives and journal publications. Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those particular cases, we utilize our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopts a robust research technique in order to deduce the market size and its estimates:
  • Examining demographic along with psychographic segmentation for market evaluation
  • Analyzing the macro and micro-economic indicators for each demography
  • Evaluating the current industry trends popular in the market.

Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:

  • Information Screening: Information screening is the way toward examining information/data gathered from the sources for errors/mistakes and amending it before data integration process. The screening includes in looking at raw information, identifying and distinguishing mistakes and managing missing information. The reason for the information screening is to ensure information is effectively entered or not. Our organization utilizes objective and precise information screening grades through repetitive quality checks.
  • Data Integration: The data integration method involves with the incorporation of numerous information streams. The data streams is important so as to deliver investigate examines that give overall market scenario to the investors. These information streams originate from different research contemplates and our in house database. After the screening of the information, our analysts conduct efficient integration of the data streams, optimizing connections between integrated surveys and syndicated data sources. There are two research approaches that we follow so as to coordinate our information; top down methodology and bottom up methodology. 
    • Top-down analysis generally refers to using broad factors as a basis for decision making. The top-down approach helps in identifying the overall market scenario along with the external and internal factors effecting the market growth.
    • The bottom-up approach takes a completely different approach. Generally, the bottom-up approach focuses its analysis on micro attributes and specific characteristics of the domain specific market.

Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.

This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.

Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.

Please fill the form below, to recieve the report sample


Our Clients

Some Facts about Fior Markets

1%

Free Customization

1+

Countries can be added on demand

1

Free yearly update on purchase of Multi/Corporate User License

1+

Companies served till date

Customized Research Programme
Premium Customer Service

We serve our customers 24x7 for 365 days through calls, emails and live chat options.

Syndicated market research
Exceptional Market Report

Huge database of exceptional market reports bringing market intelligence to your fingertips.

Domain Specific Analytics
Secured Payment Options

SSL enabled, we offer you various secured payment options for risk free purchase.